Low and high PD‐L1 expression either on tumor cells or in lymphocytes was observed in 62 (70.4%) vs 25 (28.4%) patients and in 46 (52.3%) vs 41 (46.6%) patients, respectively. This evidence concerns the gene CD274 and neoplasm.